News
Transforming the Field of Survivorship Research
Pedaling to Support LRF’s Mission One Mile at a Time
Breakthroughs Start with Strong Patient Relationships
The U.S. Food and Drug Administration Approves Pirtobrutinib (Jaypirca) for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
On December 1, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved BTK inhibitor, pirtobrutinib (Jaypirca, Eli Lilly and Company), for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have received at least two…
Lymphoma Research Foundation Raises Over $1 Million at New York City Gala to Help Eradicate Lymphoma 
Lymphoma Research Foundation Raises Over $1 Million at New York City Gala to Help Eradicate Lymphoma October 6, 2023 – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving…
First Lady of Tennessee, Maria Lee, Shares Her Experience with Lymphoma
First Lady of Tennessee, Maria Lee, Shares Her Experience with Lymphoma No one ever thinks they will hear the words, “you have cancer.” Those words rang in my ears just over one year ago, and it’s surreal to know that…